US8497385, 19B.3

ID: ALA3674587

Chembl Id: CHEMBL3674587

PubChem CID: 16090917

Max Phase: Preclinical

Molecular Formula: C49H74O13

Molecular Weight: 871.12

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCC/C=C/c1ccc([C@@H]2C[C@@H]3CCO[C@H](/C=C/C(C)(C)[C@]4(O)O[C@@H](C/C(=C\C(=O)OC)[C@@H]4OC(=O)CCCCCCC)C[C@H](CO)OC(=O)C[C@H](O)CCO2)O3)cc1

Standard InChI:  InChI=1S/C49H74O13/c1-6-8-10-12-14-15-17-35-19-21-36(22-20-35)42-33-39-25-28-58-46(60-39)23-26-48(3,4)49(55)47(61-43(52)18-16-13-11-9-7-2)37(30-44(53)56-5)29-40(62-49)32-41(34-50)59-45(54)31-38(51)24-27-57-42/h15,17,19-23,26,30,38-42,46-47,50-51,55H,6-14,16,18,24-25,27-29,31-34H2,1-5H3/b17-15+,26-23+,37-30+/t38-,39+,40+,41-,42+,46+,47+,49-/m1/s1

Standard InChI Key:  NUOLUCFREWSUJS-HAZNJANKSA-N

Associated Targets(non-human)

Prkca Protein kinase C alpha (23 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 871.12Molecular Weight (Monoisotopic): 870.5129AlogP: 8.13#Rotatable Bonds: 16
Polar Surface Area: 176.51Molecular Species: NEUTRALHBA: 13HBD: 3
#RO5 Violations: 3HBA (Lipinski): 13HBD (Lipinski): 3#RO5 Violations (Lipinski): 3
CX Acidic pKa: 10.64CX Basic pKa: CX LogP: 8.53CX LogD: 8.53
Aromatic Rings: 1Heavy Atoms: 62QED Weighted: 0.05Np Likeness Score: 1.38

References

1.  (2013)  Bryostatin analogues, synthetic methods and uses, 

Source

Source(1):